NCT04640480 2026-01-27Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With TumorsSN BioSciencePhase 1 Completed21 enrolled
NCT02331251 2018-07-02Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)Western Regional Medical CenterPhase 1/2 Terminated81 enrolled
NCT00004095 2017-04-18Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsNorthwestern UniversityPhase 1 Completed38 enrolled
NCT00031681 2013-09-307-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)National Cancer Institute (NCI)Phase 1 Completed41 enrolled